In a groundbreaking move to strengthen Africa’s healthcare system, Rwanda has launched its first syringe manufacturing plant a game-changer for vaccination efforts across the continent.

Opened on April 1 in Rwamagana District, the factory is capable of producing up to one million auto-disable syringes every day. These one-time-use syringes are designed to prevent disease transmission, especially of HIV and hepatitis, marking a major milestone in public health safety.

The plant is operated by TKMD Rwanda, a local arm of China’s Anhui Tiankang Medical Technology, and was built with the support of the Bill & Melinda Gates Foundation. It is also certified by the World Health Organization (WHO), placing it at global standards of medical equipment production.

“This is not just about syringes, it’s about saving lives and building local strength,” said Rwanda’s Minister of Health, Dr. Sabin Nsanzimana, during the launch. “It moves us closer to self-reliance in healthcare.”

Until now, most African countries have depended on syringe imports from Asia a process often slowed by supply chain delays. With the new facility, Rwanda and its neighbors can now access critical vaccination tools faster and more efficiently. A large portion of the syringes will be supplied to UNICEF for use in immunization programs across the continent.

Beyond the health impact, the factory is also an economic boost for Rwanda. More than 100 people have been employed so far, 80% of whom are women, contributing to local development and gender inclusion.

The establishment of the syringe plant signals a broader vision for Africa. Other African countries can tap into the business opportunities and potential of that the creation of the syringe plant offers.